Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: an international study based on the COVID-19 critical care consortium
Maximilian Feth,Natasha Weaver,Robert B Fanning,Sung-Min Cho,Matthew J Griffee,Mauro Panigada,Akram M Zaaqoq,Ahmed Labib,Glenn J R Whitman,Rakesh C Arora,Bo S Kim,Nicole White,Jacky Y Suen,Gianluigi Li Bassi,Giles J Peek,Roberto Lorusso,Heidi Dalton,John F Fraser,Jonathon P Fanning,COVID-19 Critical Care Consortium,Heidi J Dalton,John Laffey,Daniel Brodie,Eddy Fan,Antoni Torres,Davide Chiumello,Alyaa Elhazmi,Carol Hodgson,Shingo Ichiba,Carlos Luna,Srinivas Murthy,Alistair Nichol,Pauline Yeung Ng,Mark Ogino,Eva Marwali,Giacomo Grasselli,Robert Bartlett,Aidan Burrell,Muhammed Elhadi,Anna Motos,Ferran Barbé,Alberto Zanella
DOI: https://doi.org/10.1186/s40560-024-00726-2
2024-05-06
Abstract:Background: Extracorporeal membrane oxygenation (ECMO) is a rescue therapy in patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19. While bleeding and thrombosis complicate ECMO, these events may also occur secondary to COVID-19. Data regarding bleeding and thrombotic events in COVID-19 patients on ECMO are sparse. Methods: Using the COVID-19 Critical Care Consortium database, we conducted a retrospective analysis on adult patients with severe COVID-19 requiring ECMO, including centers globally from 01/2020 to 06/2022, to determine the risk of ICU mortality associated with the occurrence of bleeding and clotting disorders. Results: Among 1,248 COVID-19 patients receiving ECMO support in the registry, coagulation complications were reported in 469 cases (38%), among whom 252 (54%) experienced hemorrhagic complications, 165 (35%) thrombotic complications, and 52 (11%) both. The hazard ratio (HR) for Intensive Care Unit mortality was higher in those with hemorrhagic-only complications than those with neither complication (adjusted HR = 1.60, 95% CI 1.28-1.99, p < 0.001). Death was reported in 617 of the 1248 (49.4%) with multiorgan failure (n = 257 of 617 [42%]), followed by respiratory failure (n = 130 of 617 [21%]) and septic shock [n = 55 of 617 (8.9%)] the leading causes. Conclusions: Coagulation disorders are frequent in COVID-19 ARDS patients receiving ECMO. Bleeding events contribute substantially to mortality in this cohort. However, this risk may be lower than previously reported in single-nation studies or early case reports. Trial registration ACTRN12620000421932 ( https://covid19.cochrane.org/studies/crs-13513201 ).